Neuropsychiatric involvement in lupus is associated with the Nogo-a/NgR1 pathway.

Hong-Wei Lei,Jing-Yuan Wang,Qiu-Jie Dang,Fan Yang,Xin Liu,Ji-Hui Zhang,Yang Li
DOI: https://doi.org/10.1016/j.jneuroim.2017.06.008
IF: 3.221
2017-01-01
Journal of Neuroimmunology
Abstract:Neuroinflammation- and neurodegeneration-induced nerve injury may represent important components of neuropsychiatric lupus (NPSLE). Myelin-associated neurite outgrowth inhibitor (Nogo)-a and its receptor, NgR1, limit recovery of the adult central nervous system after injury. We detected a soluble Nogo-a product in the cerebral spinal fluid of patients with NPSLE. In a mouse model of lupus, aging was associated with an increase in Nogo-a positive neurons, diminished myelin sheaths, enhanced pro-inflammatory cytokines, and impaired cognition and memory. Treatment with the Nogo-66 antagonist promoted myelin repair, improved cognition and memory, and downregulated pro-inflammatory factors. Our data imply the Nogo-a/NgR1 pathway is involved in NPSLE.
What problem does this paper attempt to address?